These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 11966396)
1. Pharmacogenomics and pharmacogenetics of neurodegenerative diseases: towards new targets. Amouyel P Pharmacogenomics; 2002 Jan; 3(1):1-3. PubMed ID: 11966396 [No Abstract] [Full Text] [Related]
2. [Neurodegenerative disorders: the role of genetic factors in their origin and the efficiency of treatment]. Sukhanov VA; Ionov ID; Piruzian LA Fiziol Cheloveka; 2005; 31(4):119-30. PubMed ID: 16122046 [No Abstract] [Full Text] [Related]
3. [Apolipoprotein E and bleomycin hydrolase. Polymorphisms: association with neurodegenerative diseases]. Nivet-Antoine V; Coulhon MP; Le Denmat C; Hamon B; Dulcire X; Lefebvre M; Piette F; Davous P; Durand D; Duchassaing D Ann Biol Clin (Paris); 2003; 61(1):61-7. PubMed ID: 12604387 [TBL] [Abstract][Full Text] [Related]
4. The application of functional genomics to Alzheimer's disease. Cacabelos R Pharmacogenomics; 2003 Sep; 4(5):597-621. PubMed ID: 12943467 [TBL] [Abstract][Full Text] [Related]
5. [Pharmacogenomics - a promise in clinical practice]. Bredeţean O; Ciochină AD Rev Med Chir Soc Med Nat Iasi; 2000; 104(4):7-10. PubMed ID: 12089963 [No Abstract] [Full Text] [Related]
7. Pharmacogenetics and pharmacogenomics of sexual dysfunction: current status, gaps and potential applications. Abdel-Hamid IA; Andersson KE Pharmacogenomics; 2009 Oct; 10(10):1625-44. PubMed ID: 19842936 [TBL] [Abstract][Full Text] [Related]
8. [Prospects of medicinal use of achievements in genomics: the beginning of era of complete genome medical genetics]. Sverdlov ED Patol Fiziol Eksp Ter; 2001; (1):3-22. PubMed ID: 11247299 [No Abstract] [Full Text] [Related]
9. Pharmacogenomics: the implementation phase. Sadee W AAPS PharmSci; 2002; 4(2):E5. PubMed ID: 12141268 [TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics in Alzheimer's disease. Cacabelos R Methods Mol Biol; 2008; 448():213-357. PubMed ID: 18370236 [TBL] [Abstract][Full Text] [Related]
13. [Drug therapy at the beginning of the genomic era]. Stoica O; Braha E; Ungureanu G Rev Med Chir Soc Med Nat Iasi; 2002; 107(2):240-6. PubMed ID: 12638267 [TBL] [Abstract][Full Text] [Related]
15. Fast forwarding pharmacogenomics. Jung V Pharmacogenomics; 2002 May; 3(3):281-5. PubMed ID: 12052137 [No Abstract] [Full Text] [Related]
16. Genomic medicines for oncology: early lessons. Simons JW J Med Assoc Ga; 2003; 92(1):35-8. PubMed ID: 12743904 [No Abstract] [Full Text] [Related]
17. Pharmacogenomics: bench to bedside. Weinshilboum R; Wang L Nat Rev Drug Discov; 2004 Sep; 3(9):739-48. PubMed ID: 15340384 [TBL] [Abstract][Full Text] [Related]
18. A critical assessment of the role of pharmacogenomics and pharmacogenetics approaches to cardiovascular diseases. Amouyel P Pharmacogenomics J; 2001; 1(2):95-7. PubMed ID: 11911447 [No Abstract] [Full Text] [Related]
19. Moving towards individualized medicine with pharmacogenomics. Evans WE; Relling MV Nature; 2004 May; 429(6990):464-8. PubMed ID: 15164072 [TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics and pharmacogenetics. 1st Spanish Congress on Pharmacogenomics and Pharmacogenetics, January 23-25, 2005, Valencia, Spain. Iqbal O Pharmacogenomics; 2005 Apr; 6(3):205-7. PubMed ID: 16013951 [No Abstract] [Full Text] [Related] [Next] [New Search]